BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 18685005)

  • 21. Rapid identification of Burkholderia cepacia complex species including strains of the novel Taxon K, recovered from cystic fibrosis patients by intact cell MALDI-ToF mass spectrometry.
    Miñán A; Bosch A; Lasch P; Stämmler M; Serra DO; Degrossi J; Gatti B; Vay C; D'aquino M; Yantorno O; Naumann D
    Analyst; 2009 Jun; 134(6):1138-48. PubMed ID: 19475140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delineation of Stenotrophomonas maltophilia isolates from cystic fibrosis patients by fatty acid methyl ester profiles and matrix-assisted laser desorption/ionization time-of-flight mass spectra using hierarchical cluster analysis and principal component analysis.
    Vidigal PG; Mosel F; Koehling HL; Mueller KD; Buer J; Rath PM; Steinmann J
    J Med Microbiol; 2014 Dec; 63(Pt 12):1615-1620. PubMed ID: 25266870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Capillary electrophoresis-single-strand conformation polymorphism analysis for rapid identification of Pseudomonas aeruginosa and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis.
    Ghozzi R; Morand P; Ferroni A; Beretti JL; Bingen E; Segonds C; Husson MO; Izard D; Berche P; Gaillard JL
    J Clin Microbiol; 1999 Oct; 37(10):3374-9. PubMed ID: 10488211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Rapid Detection of Isolates Belonging to the Epidemic Clones Achromobacter xylosoxidans ST137 and Achromobacter ruhlandii DES from Cystic Fibrosis Patients.
    Garrigos T; Dollat M; Magallon A; Chapuis A; Varin V; Bador J; Makki N; Cremet L; Persyn E; Cardot-Martin E; Echahidi F; Peeters C; Pierard D; Vandamme P; Verroken A; Neuwirth C; Amoureux L
    J Clin Microbiol; 2021 Sep; 59(10):e0094621. PubMed ID: 34346714
    [No Abstract]   [Full Text] [Related]  

  • 25. Rapid identification of Gram-negative organisms from blood culture bottles using a modified extraction method and MALDI-TOF mass spectrometry.
    Gray TJ; Thomas L; Olma T; Iredell JR; Chen SC
    Diagn Microbiol Infect Dis; 2013 Oct; 77(2):110-2. PubMed ID: 23891220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MALDI-TOF MS improves routine identification of non-fermenting Gram negative isolates from cystic fibrosis patients.
    Fernández-Olmos A; García-Castillo M; Morosini MI; Lamas A; Máiz L; Cantón R
    J Cyst Fibros; 2012 Jan; 11(1):59-62. PubMed ID: 21968086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discrepancy in MALDI-TOF MS identification of uncommon Gram-negative bacteria from lower respiratory secretions in patients with cystic fibrosis.
    AbdulWahab A; Taj-Aldeen SJ; Ibrahim EB; Talaq E; Abu-Madi M; Fotedar R
    Infect Drug Resist; 2015; 8():83-8. PubMed ID: 25995646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multi-center evaluation of the VITEK® MS system for mass spectrometric identification of non-Enterobacteriaceae Gram-negative bacilli.
    Manji R; Bythrow M; Branda JA; Burnham CA; Ferraro MJ; Garner OB; Jennemann R; Lewinski MA; Mochon AB; Procop GW; Richter SS; Rychert JA; Sercia L; Westblade LF; Ginocchio CC
    Eur J Clin Microbiol Infect Dis; 2014 Mar; 33(3):337-46. PubMed ID: 24019163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of pyrrolidonyl arylamidase for the identification of nonfermenting Gram-negative rods.
    Bombicino KA; Almuzara MN; Famiglietti AM; Vay C
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):101-3. PubMed ID: 16822636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of AmpC β-lactamase-producing Gram-negative bacteria by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Li C; Ding S; Huang Y; Wang Z; Shen J; Ling H; Xu Y
    J Hosp Infect; 2018 Jun; 99(2):200-207. PubMed ID: 29175433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matrix-assisted laser desorption ionisation-time-of of-flight mass spectrometry of intact cells allows rapid identification of Burkholderia cepacia complex.
    Vanlaere E; Sergeant K; Dawyndt P; Kallow W; Erhard M; Sutton H; Dare D; Devreese B; Samyn B; Vandamme P
    J Microbiol Methods; 2008 Oct; 75(2):279-86. PubMed ID: 18627778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid identification of Burkholderia cepacia complex species recovered from cystic fibrosis patients using matrix-assisted laser desorption ionization time-of-flight mass spectrometry.
    Lambiase A; Del Pezzo M; Cerbone D; Raia V; Rossano F; Catania MR
    J Microbiol Methods; 2013 Feb; 92(2):145-9. PubMed ID: 23201483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid identification of Staphylococci isolated in clinical microbiology laboratories by matrix-assisted laser desorption ionization-time of flight mass spectrometry.
    Carbonnelle E; Beretti JL; Cottyn S; Quesne G; Berche P; Nassif X; Ferroni A
    J Clin Microbiol; 2007 Jul; 45(7):2156-61. PubMed ID: 17507519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of a matrix-assisted laser desorption ionization-time-of-flight mass spectrometry system for the identification of bacterial isolates in the clinical routine laboratory.
    Eigner U; Holfelder M; Oberdorfer K; Betz-Wild U; Bertsch D; Fahr AM
    Clin Lab; 2009; 55(7-8):289-96. PubMed ID: 19894408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of 16S rRNA gene sequencing for identification of "Pseudomonas-like" isolates from sputum of patients with cystic fibrosis].
    Moissenet D; Bingen E; Arlet G; Vu-Thien H
    Pathol Biol (Paris); 2005; 53(8-9):500-2. PubMed ID: 16081224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis.
    Kiska DL; Kerr A; Jones MC; Caracciolo JA; Eskridge B; Jordan M; Miller S; Hughes D; King N; Gilligan PH
    J Clin Microbiol; 1996 Apr; 34(4):886-91. PubMed ID: 8815102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multicenter validation of the VITEK MS v2.0 MALDI-TOF mass spectrometry system for the identification of fastidious gram-negative bacteria.
    Branda JA; Rychert J; Burnham CA; Bythrow M; Garner OB; Ginocchio CC; Jennemann R; Lewinski MA; Manji R; Mochon AB; Procop GW; Richter SS; Sercia LF; Westblade LF; Ferraro MJ
    Diagn Microbiol Infect Dis; 2014 Feb; 78(2):129-31. PubMed ID: 24321357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Side by Side Comparison of Bruker Biotyper and VITEK MS: Utility of MALDI-TOF MS Technology for Microorganism Identification in a Public Health Reference Laboratory.
    Lévesque S; Dufresne PJ; Soualhine H; Domingo MC; Bekal S; Lefebvre B; Tremblay C
    PLoS One; 2015; 10(12):e0144878. PubMed ID: 26658918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Confirmation and Identification of
    Bastin B; Bird P; Benzinger MJ; Crowley E; Agin J; Goins D; Sohier D; Timke M; Shi G; Kostrzewa M
    J AOAC Int; 2018 Sep; 101(5):1593-1609. PubMed ID: 29703270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimization of routine identification of clinically relevant Gram-negative bacteria by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry and the Bruker Biotyper.
    Ford BA; Burnham CA
    J Clin Microbiol; 2013 May; 51(5):1412-20. PubMed ID: 23426923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.